London Stock Exchange welcomes Hipgnosis songs fund limited to the Specialist Fund Segment

London Stock Exchange today welcomed Hipgnosis Songs Fund Limited to trading on the Specialist Fund Segment of the Main Market.

Founded by Merck Mercuriadis, Hipgnosis Songs Fund is the only fund listed on the London Stock Exchange that offers investors pure-play exposure to Songs and associated music IP rights and has raised over £200m in an oversubscribed fundraising. 

Hipgnosis Songs Fund will take advantage of a unique market opportunity as technology disruption is changing the way music is consumed. The pace at which revenues from music streaming replace and increase those earned from physical and permanent download sales is forecast to grow significantly. This is driven in large measures by music consumers switching from illegal downloading to convenient and legal streaming, which is resulting in improved monetisation of music.

Hipgnosis Songs Fund is advised by The Family (Music) Limited which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N’ Roses, Morrissey and Iron Maiden, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. Merck is supported by an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing including Nile Rodgers, Terius “The Dream” Nash, Bill Leibowitz, Ian Montone, and Jason Flom.

Merck Mercuriadis, Founder and CEO of The Family (Music) Limited, said:

“I believe the song, even more so than the artist, is the most important component in a hit recording. The music industry has been built on the predictable, reliable and enduring income they provide and now thanks to the systemic change in the way music is consumed via streaming the pie is growing rapidly. I’m delighted that the financial community is supporting our thesis that the proven hit songs we are targeting for acquisition are very investable assets and I look forward to updating the market on the progress of acquisitions soon. 
I’ve spent the better part of the last 35 years advocating for great artists, songwriters and producers and my ambition is to grow our fund not only to provide great returns for our investors but equally well in due course to create the leverage that only critical mass can provide to change the songwriters position in the economic model.”

Andrew Sutch, Chairman of Hipgnosis Songs Fund Limited, said:

“I'm delighted that the Hipgnosis Songs Fund launch has been so well-supported by investors, Hipgnosis will now be the first fund listed on the London Stock Exchange that offers investors pure-play exposure to Songs and associated music IP rights. 
On behalf of the Board, we are excited to work with Merck and the rest of The Family (Music) Limited as they look to utilise their extensive industry experience and relationships to identify, acquire and manage Songs.”
N+1 Singer acted as financial adviser and bookrunner and Herbert Smith Freehills as legal counsel.

Quick facts

Track
Market: Main Market
Instrument market cap (£m)
1,489.79
Listing/Admission to trading
11 Jul 2018
Looking for new and recent issues?

More recent

London Stock Exchange welcomes Castelnau Group Limited to the Specialist Fund Segment to the Main Market

The London Stock Exchange today welcomes Castelnau Group Limited (‘Castelnau’), an investment company established to invest in public and private companies with the aim of outperforming the FTSE All Share Total Return Index over the long term.  The ordinary shares of Castlenau will be listed on the Specialist Fund Segment of the Main Market.</

Learn more
London Stock Exchange welcomes Light Science Technologies Holdings plc

Today, London Stock Exchange welcomes Light Science Technologies Holdings plc (“LSTH”) to trading on AIM under the ticker LST. In October 2021, LSTH successfully raised gross proceeds of £5 million (the “Placing”) and the Company’s market capitalisation on admission was approximately £17.5 million.

The net proceeds of the Placing, which are receivable by the

Learn more
149.96
London Stock Exchange welcomes Oxford Nanopore Technologies plc to the Main Market

London Stock Exchange welcomes Oxford Nanopore Technologies plc to the Main Market of the London Stock Exchange. Founded in 2005 by Gordon Sanghera, Spike Willcocks and Professor Hagan Bayley, Oxford Nanopore has developed a new generation of nanopore-based sensing technology.

Oxford Nanopore’s long term goal is to bring the widest benefits to society throug

Learn more
London Stock Exchange welcomes BioPharma Credit plc to the Premium Segment of the Main Market

BioPharma Credit, the specialist life sciences debt investor, today announces that its London listing has moved from the Specialist Fund Segment to the Premium Segment of the Main Market of London Stock Exchange. The Company’s objective in joining the Main Market is to raise the Company’s global profile, extend its potential shareholder base, and e

Learn more